Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | PRKCA | P17252 | 2/20 | 0.37 |
| ▸ | FAAH | O00519 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
| ▸ | PAM | P19021 | 2/20 | 0.34 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid Methyl Ester SCHEMBL8869579 | 0.83 | EPHX1 (0.44) | TSHRFAAHMEN1MAPTKMT2A | |
| Isopropyl Myristate SCHEMBL31620684 | 0.83 | LMNA (0.72) | LMNATSHRPRKCAMEN1MAPT | |
| SCHEMBL19066786 | 0.82 | CES2 (0.47) | TSHRMEN1KMT2ACES2 | |
| SCHEMBL1115965 | 0.82 | CES2 (0.47) | TSHRMEN1KMT2ACES2 | |
| SCHEMBL1898129 | 0.82 | CES2 (0.47) | TSHRMEN1KMT2ACES2 | |
| SCHEMBL168633 | 0.82 | CES2 (0.47) | TSHRMEN1KMT2ACES2 | |
| Octane SCHEMBL10883673 | 0.82 | TSHR (0.67) | LMNATSHRPRKCAFAAHMEN1 | |
| SCHEMBL20563871 | 0.82 | CES2 (0.47) | TSHRMEN1KMT2ACES2 | |
| SCHEMBL20853607 | 0.82 | CES2 (0.47) | TSHRMEN1KMT2ACES2 | |
| Heptane SCHEMBL2123028 | 0.82 | TSHR (0.67) | LMNATSHRPRKCAFAAHMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8211455-B2 | Implantable or insertable medical devices for controlled delivery of a therapeutic agent | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2012-07-03 | — | — | US | disclosed |
| EP-1513565-B1 | IMPLANTABLE OR INSERTABLE MEDICAL DEVICES FOR CONTROLLED DELIVERY OF A THERAPEUTIC AGENT | BOSTON SCIENT LTD (BB) | 2012-01-25 | — | — | EP | disclosed |
| US-20110123594-A1 | Implantable or Insertable Medical Devices For Controlled Delivery of a Therapeutic Agent | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2011-05-26 | — | — | US | disclosed |
| US-7939094-B2 | Comprises implantable/insertable implants (catheter, stents) | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2011-05-10 | — | — | US | disclosed |
| US-7901702-B2 | Implantable or insertable medical devices for controlled delivery of a therapeutic agent | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2011-03-08 | — | — | US | disclosed |
| US-7901726-B2 | Porous medical articles for therapeutic agent delivery | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2011-03-08 | — | — | US | disclosed |
| WO-2009032665-A2 | POROUS MEDICAL ARTICLES FOR THERAPEUTIC AGENT DELIVERY | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2009-03-12 | — | — | WO | disclosed |
| US-20090061071-A1 | Porous medical articles for therapeutic agent delivery | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2009-03-05 | — | — | US | disclosed |
| US-20080311173-A1 | IMPLANTABLE OR INSERTABLE MEDICAL DEVICES FOR CONTROLLED DELIVERY OF A THERAPEUTIC AGENT | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2008-12-18 | — | — | US | disclosed |
| US-20070003599-A1 | Implantable or insertable medical devices for controlled delivery of a therapeutic agent | SCHWARZ MARLENE C | 2007-01-04 | — | — | US | disclosed |
| WO-2004000380-A1 | IMPLATABLE OR INSERTABLE MEDICAL DEVICES FOR CONTROLLED DELIVERY OF A THERAPEUTIC AGENT | SCIMED LIFE SYSTEMS, INC. (US) | 2003-12-31 | — | — | WO | disclosed |
| WO-2004000267-A1 | METHOD FOR MODULATION OF DRUG RELEASE FROM MULTIPHASE IMPLANTABLE OR INSERTABLE MEDICAL DEVICES AND A PROCESS FOR MANUFACTURING SUCH DEVICES | SCIMED LIFE SYTEMS, INC. (US) | 2003-12-31 | — | — | WO | disclosed |
| WO-2004000381-A1 | IMPLANTABLE OR INSERTABLE MEDICAL DEVICES FOR CONTROLLED DELIVERY OF A THERAPEUTIC AGENT | SCIMED LIFE SYSTEMS, INC. (US) | 2003-12-31 | — | — | WO | disclosed |
| WO-2004000384-A1 | IMPLANTABLE OR INSERTABLE MEDICAL DEVICES FOR CONTROLLED DELIVERY OF A THERAPEUTIC AGENT | SCIMED LIFE SYSTEMS, INC. (US) | 2003-12-31 | — | — | WO | disclosed |
| US-20030235603-A1 | Multiphase polymeric drug release region | BOSTON SCIENTIFIC SCIMED, INC. | 2003-12-25 | — | — | US | disclosed |
| US-20030236514-A1 | Implantable or insertable medical devices for controlled delivery of a therapeutic agent | BOSTON SCIENTIFIC SCIMED, INC. | 2003-12-25 | — | — | US | disclosed |
| US-20030236513-A1 | Implantable or insertable medical devices for controlled delivery of a therapeutic agent | SCIMED LIFE SYSTEMS, INC. | 2003-12-25 | — | — | US | disclosed |
| US-20030235602-A1 | Implantable or insertable medical devices for controlled delivery of a therapeutic agent | BOSTON SCIENTIFIC SCIMED, INC. | 2003-12-25 | — | — | US | disclosed |
| WO-2003090806-A1 | MODULATION OF THERAPEUTIC AGENT RELEASE FROM A POLYMERIC CARRIER USING SOLVENT-BASED TECHNIQUES | SCIMED LIFE SYSTEMS, INC. (US) | 2003-11-06 | — | — | WO | disclosed |
| US-20030203000-A1 | Modulation of therapeutic agent release from a polymeric carrier using solvent-based techniques | BOSTON SCIENTIFIC SCIMED, INC. | 2003-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030203000-A1 | Modulation of therapeutic agent release from a polymeric carrier using solvent-based techniques | ABCB11, LPXN, LIPA | LMNA 3497/4885TSHR 1872/4885PRKCA 2257/4885 |
| US-20030235603-A1 | Multiphase polymeric drug release region | ABCB11, ABCB1, PIK3R1 | LMNA 1886/4885TSHR 2123/4885PRKCA 2390/4885 |
| US-20030236514-A1 | Implantable or insertable medical devices for controlled delivery of a therapeutic agent | MLEC, CA6, MIF | LMNA 1397/4885TSHR 4429/4885PRKCA 1023/4885 |
| US-20110123594-A1 | Implantable or Insertable Medical Devices For Controlled Delivery of a Therapeutic Agent | MIF, PAICS, IDUA | LMNA 2922/4885TSHR 2108/4885PRKCA 2296/4885 |
| US-20030236513-A1 | Implantable or insertable medical devices for controlled delivery of a therapeutic agent | PAICS, MIF, PGF | LMNA 1827/4885TSHR 2465/4885PRKCA 671/4885 |
| US-20080311173-A1 | IMPLANTABLE OR INSERTABLE MEDICAL DEVICES FOR CONTROLLED DELIVERY OF A THERAPEUTIC AGENT | PAICS, MIF, PGF | LMNA 1827/4885TSHR 2465/4885PRKCA 671/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.